inclusion criteria: 1. participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. 2. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. 3. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp \> 70 mg/l 4. participants who are hospitalized and receiving supportive care for covid-19. 5. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.

inclusion criteria: 1. participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. 2. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. 3. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp \> 70 mg/l 4. participants who are hospitalized and receiving supportive care for covid-19. 5. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.

inclusion criteria: participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp > 70 mg/l participants who are hospitalized and receiving supportive care for covid-19. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.

inclusion criteria: participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp > 70 mg/l participants who are hospitalized and receiving supportive care for covid-19. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.

inclusion criteria: 1. participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. 2. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. 3. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp > 70 mg/l 4. participants who are hospitalized and receiving supportive care for covid-19. 5. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.

inclusion criteria: 1. participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. 2. participants with laboratory-confirmed novel coronavirus (sars-cov-2) infection as determined by polymerase chain reaction (pcr) or other commercially available or public health assay prior to day 1. 3. participants with evidence of pneumonia assessed by radiographic imaging (chest x ray or chest ct scan) and requiring ≥ 3l o2 or ≥ 2l o2 and hscrp > 70 mg/l 4. participants who are hospitalized and receiving supportive care for covid-19. 5. participant (or legally authorized representative/surrogate) capable of giving signed informed consent.